All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @doctorjarrett on Instagram · 39s|Watch on Instagram
Full video transcriptClick to expand

Auto-generated transcript of @doctorjarrett's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Everyone's talking about this popular supplement, but can it really restore your cells to teenage level energy?
  2. 0:05Longevity researcher and biohacker Brian Johnson tested two popular NAD plus precursors,
  3. 0:11NMN and N-R. Over 90 days, he measured his intracellular NAD plus levels and found that they were comparable to a 16-year-old.
  4. 0:18But here's the kicker, NMN and N-R are just precursors. Your body still has to convert them.
  5. 0:23NAD plus shots deliver the active molecule directly to the bloodstream for 100% bioavailability.
  6. 0:29This bypass's digestion, which is why people notice effects faster almost immediately.
  7. 0:34If you want a clear breakdown and all the benefits, comment NAD and I'll send it.

Bryan Johnson's NAD+ claims need more evidence

Dr. Jarrett Schanzer

Instagram creator

20.6K viewsView on Instagram

Quick answer

NAD+ levels do decline with age and precursor supplementation with NMN or NR has demonstrated the ability to raise NAD+ biomarkers in peer-reviewed human trials, though no controlled study has replicated the specific "teenage level" outcome described in this video. Injectable NAD+ administration raises blood levels more rapidly than oral precursors, but the clinical significance of that speed advantage over oral routes for most patients remains unestablished in head-to-head trials. Any decision about NAD+ supplementation form or route should involve a licensed provider who can assess baseline levels and individual health context.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksNAD+ Peptide ComplexProvider discussion

Evidence signal

Source-backed review

Regulatory reality

NAD+ Peptide Complex access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Bryan Johnson's NAD+ claims need more evidence, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

NAD+ Peptide Complex is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this nad+ video claims cluster

Best for searchers separating NAD+ longevity marketing from practical metabolic and safety questions.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "Bryan Johnson's NAD+ claims need more evidence" from Dr. Jarrett Schanzer. We read the clip as a Peptide social video fact-checks claim about NAD+ Peptide Complex, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: NAD+ levels do decline with age and precursor supplementation with NMN or NR has demonstrated the ability to raise NAD+ biomarkers in peer-reviewed human trials, though no controlled study has replicated the specific "teenage level" outcome described in this video.

The reason this review is not generic is the source wording and the canonical claim label "peptides can nad levels really reach teenage range again or is th." In this clip, the useful excerpt is: "Everyone's talking about this popular supplement, but can it really restore your cells to teenage level energy?" That wording changes the review because it points to NAD+ Peptide Complex safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against NAD+ metabolism and its roles in cellular processes during ageing (2021), Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women (2021), and Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults (2018), plus the creator's own wording. NAD+ Peptide Complex still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Human trials confirm oral precursors work: Martens et al.
People who land here are usually comparing the NAD+ Peptide Complex claim with NAD, Longevity, and Biohacking.
The strongest next step is to compare the claim with FormBlends' NAD+ Peptide Complex guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

NAD+ levels do decline with age and precursor supplementation with NMN or NR has demonstrated the ability to raise NAD+ biomarkers in peer-reviewed human trials, though no controlled study has replicated the specific "teenage level" outcome described in this video.

FormBlends verdict

NAD+ Peptide Complex safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the NAD+ Peptide Complex guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • NAD+ levels do decline with age and precursor supplementation with NMN or NR has demonstrated the ability to raise NAD+ biomarkers in peer-reviewed human trials, though no controlled study has replicated the specific "teenage level" outcome described in this video. Injectable NAD+ administration raises blood levels more rapidly than oral precursors, but the clinical significance of that speed advantage over oral routes for most patients remains unestablished in head-to-head trials. Any decision about NAD+ supplementation form or route should involve a licensed provider who can assess baseline levels and individual health context.
  • NAD+ does decline with age: Zhu et al. (2015, Cell Metabolism) documented age-related NAD+ reduction in tissues, making the general premise of supplementation biologically reasonable.
  • Human trials confirm oral precursors work: Martens et al. (2018, Nature Communications) showed NR raised whole-blood NAD+ by approximately 60% in older adults taking oral supplements.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • NAD+ Peptide Complex decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the NAD+ Peptide Complex guide, cost path, safety notes, and provider review before acting.

Review NAD+ Peptide Complex

What You'll Learn

  • NAD+ does decline with age: Zhu et al. (2015, Cell Metabolism) documented age-related NAD+ reduction in tissues, making the general premise of supplementation biologically reasonable.
  • Human trials confirm oral precursors work: Martens et al. (2018, Nature Communications) showed NR raised whole-blood NAD+ by approximately 60% in older adults taking oral supplements.
  • Bryan Johnson's data is n=1 self-experimentation, not a controlled study. His results cannot be treated as evidence of what any supplement will do for a different person.
  • "100% bioavailability" only applies to intravenous administration by definition. Intramuscular and subcutaneous injections have lower and variable absorption rates depending on the compound and individual.
  • Raising a NAD+ biomarker is not the same as reversing biological aging. No peer-reviewed human trial has demonstrated that NAD+ supplementation restores tissue function to a younger biological age.
  • The speed advantage of injectable versus oral NAD+ precursors has not been established in head-to-head clinical trials as meaningfully different for long-term outcomes.
  • Any NAD+ supplementation, especially injectable forms, should be evaluated by a licensed provider based on your individual baseline levels, health history, and clinical goals.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @doctorjarrett actually say?

The video makes three distinct claims worth separating. First, that Bryan Johnson tested NMN and NR over 90 days and found his intracellular NAD+ levels were "comparable to a 16-year-old." Second, that NMN and NR are just precursors your body has to convert. Third, and most aggressively, that NAD+ injections deliver "100% bioavailability" and "bypass digestion," which is why people feel effects "almost immediately." That last part is where the video stops reporting and starts selling.

The Bryan Johnson reference is real, broadly speaking. Johnson has publicly shared biometric data including NAD+ measurements through his Blueprint protocol and has discussed precursor supplementation. But the framing of "teenage" NAD+ levels and what that actually means for human health is where things get complicated fast.

Does the science back this up?

The precursor biology is correct. NMN and NR are not NAD+ itself. They are substrates that cells convert through enzymatic pathways, primarily via the salvage pathway. This is established biochemistry, not controversy. The question is whether that conversion is a meaningful limitation in healthy adults.

On the "teenage levels" claim: NAD+ does decline with age. That part is well-documented. Zhu et al. (2015, Cell Metabolism) showed age-related NAD+ decline in tissues. Yoshino et al. (2021, Science) demonstrated that NMN supplementation raised skeletal muscle NAD+ levels in postmenopausal women. But "comparable to a 16-year-old" is a specific, extraordinary claim. Bryan Johnson's self-reported data is n=1 biohacking, not a controlled trial. Intracellular NAD+ measurements also vary significantly by tissue, methodology, and time of day. Treating one man's lab result as generalizable evidence is a stretch.

On injection bioavailability: intravenous NAD+ does raise blood NAD+ levels rapidly. But "100% bioavailability" for any injection route requires clarification. Intramuscular and subcutaneous injections are not 100% bioavailable by definition. Only intravenous administration achieves that, and even then, how much reaches intracellular compartments where it actually functions is a separate question the video completely ignores.

What did they get wrong (or right)?

Credit where it is due: the point that NMN and NR require conversion is accurate and genuinely useful context most supplement marketing skips entirely. That is a fair and honest disclosure.

What they got wrong is the bioavailability claim. Saying NAD+ shots deliver "100% bioavailability" is imprecise at best and misleading at worst. A 2023 review by Airhart et al. (Nutrients) noted that oral NR actually achieves meaningful systemic NAD+ elevation despite the conversion step, and the clinical gap between oral and injectable routes is not as dramatic as the video implies. The claim that injections cause effects "almost immediately" is anecdotal framing dressed as pharmacokinetics.

The Bryan Johnson angle is also being used as a credibility shortcut. Johnson is a self-experimenter with significant resources, not a clinical researcher. His data is interesting but it is not evidence that a supplement will replicate the same results in a different person with different baseline NAD+ levels, genetics, or health status.

What should you actually know?

NAD+ precursor supplementation has real, peer-reviewed support for raising NAD+ levels in humans. Martens et al. (2018, Nature Communications) showed NR supplementation increased whole-blood NAD+ by roughly 60% in older adults. That is meaningful. But raising a biomarker is not the same as reversing aging or achieving "teenage" cellular function. No study has demonstrated that outcome in humans.

If you are considering any NAD+ supplementation, including injectable forms, the route of administration, dosing, and whether you are a good candidate is a clinical conversation, not something to decide based on a 60-second Instagram video referencing one person's biohacking results. Injectable NAD+ is used in clinical settings and has a real pharmacological profile, but the "bypass digestion for instant results" framing is marketing language, not a clinical recommendation.

The video ends with a call to comment for more information, which is a lead-generation tactic. That does not make the information wrong, but it is worth knowing the context in which the claims are being made.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Dr. Jarrett Schanzer · Instagram creator

20.6K views on this video

Can NAD+ levels really reach “teenage” range again… or is that just biohacking hype? Longevity researcher Bryan Johnson publicly tested two popular NAD+ precursors:NMN and NR over a 90-day period. He

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about nad+ does decline with age: zhu et al. (2015, cell?

NAD+ does decline with age: Zhu et al. (2015, Cell Metabolism) documented age-related NAD+ reduction in tissues, making the general premise of supplementation biologically reasonable.

What does the video say about human trials confirm?

Human trials confirm oral precursors work: Martens et al. (2018, Nature Communications) showed NR raised whole-blood NAD+ by approximately 60% in older adults taking oral supplements.

What does the video say about bryan johnson's data?

Bryan Johnson's data is n=1 self-experimentation, not a controlled study. His results cannot be treated as evidence of what any supplement will do for a different person.

What does the video say about "100% bioavailability" only applies to intravenous administration by definition. intramuscular?

"100% bioavailability" only applies to intravenous administration by definition. Intramuscular and subcutaneous injections have lower and variable absorption rates depending on the compound and individual.

What does the video say about raising a nad+ biomarker?

Raising a NAD+ biomarker is not the same as reversing biological aging. No peer-reviewed human trial has demonstrated that NAD+ supplementation restores tissue function to a younger biological age.

What does the video say about the speed advantage of injectable versus?

The speed advantage of injectable versus oral NAD+ precursors has not been established in head-to-head clinical trials as meaningfully different for long-term outcomes.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Dr. Jarrett Schanzer, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.